Ohio_Patient_Network

  • Increase font size
  • Default font size
  • Decrease font size
Home Legislation Pending HB 2835 Medical Marijuana Patient Protection Act 2009

HB 2835 Medical Marijuana Patient Protection Act 2009

Twenty-nine congressmen have introduced House Bill 2835, "The Medical Marijuana Patient Protection Act of 2009."  We need to to get more Ohio Congressional Representatives to support this bill.  The bill will provide legal protections for state-authorized medical marijuana patients.  More importantly, the bill would move marijuana from a Schedule I drug to a Schedule II drug.

A schedule one drug fits all the follwing criteria;
(A) The drug or other substance has a high potential for abuse;
(B) The drug or other substance has no currently accepted medical use in treatment in the United States;
(C) There is a lack of accepted safety for use of the drug or other substance under medical supervision.

The last criteria is interesting; a rational interpretation is that even a doctor could not use marijuana safely.  So, another way of defining marijuana, is that it is deadly, addictive, and with no medical use.

This bill would recognize marijuana's medical value and make it possible for the FDA to begin setting up a regulatory framework for its use.  Please contact your congressional representative.  Below are links to some internet resources to make contact, but the best way is to drop by their local home office and make your voice heard directly via using their own staff.  There is a link on our sidebar to find out who your representative is.  Also it would be beneficial to talk to your Ohio state senators and representatives also.

NORML's CAPWIZ - Sends letter or email MPP -  Sends an email

When you get a response, please send a copy to OPN at 1620 E. Broad St, Suite 1603, Columbus, Ohio, 43203 or use our email INFO at ohiopatientsnetwork.org.

 

Medical Marijuana News

Maternal Tobacco and Alcohol Use, But Not Marijuana, Associated With Psychotic Symptoms In Offspring, Study Says

Wales, United Kingdom: The maternal use of tobacco and alcohol during pregnancy is linked with increased incidences of psychotic symptoms in adolescents, according to the results of a longitudinal study published in the October issue of The British Journal of Psychiatry.

Investigators at the University of Bristol in Great Britain assessed whether maternal use of tobacco, alcohol, or cannabis during pregnancy increased the risk of psychotic symptoms in their offspring. Researchers examined the drug use habits of the mothers of over 6,300 adolescents – approximately 12 percent of which exhibited some symptoms of psychosis.

Authors concluded: "Frequency of maternal tobacco use during pregnancy was associated with increased risk of suspect or definite psychotic symptoms (in offspring.) Maternal alcohol use shows a non-linear association with psychotic symptoms, with this effect almost exclusively in the offspring of women drinking >21 units (approximately a half-pint of beer or a glass of wine) weekly. Maternal cannabis was not associated with psychotic symptoms."

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, "Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring," appears in the British Journal of Psychiatry.